PlainRecalls
FDA Drug Low Class III Terminated

Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24.

Reported: August 15, 2018 Initiated: August 1, 2018 #D-1035-2018

Product Description

Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24.

Reason for Recall

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Details

Units Affected
106,320 bags
Distribution
Nationwide USA and Puerto Rico
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24.. Recalled by Baxter Healthcare Corporation. Units affected: 106,320 bags.
Why was this product recalled?
Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 15, 2018. Severity: Low. Recall number: D-1035-2018.